About the Journal | Editorial Board | Instructions to Contributors | Submission & Review | Advertise with Us | Subscribe to E- Alerts
Sitemap | Feedback
Advanced search
Journal of Case Reports
Disseminated Geotrichosis in Prolonged Neutropenia
Arun Prabhakaran Nair1, Sreethish Sasi2, Rakesh Parakadavathu1, Mohammed Abukhattab1, Samar Mahmoud Hashim1, Suleiman Abu Jarir1, Muna Al-Maslamani1
1Department of Infectious Diseases, Communicable Disease Center; 2Department of Internal Medicine and Medical Education, Hamad General Hospital, Hamad Medical Corporation, Doha, Qatar.
Corresponding Author:
Dr. Sreethish Sasi
Email: sreethishsasi@gmail.com
Received: 05-MAR-2020 Accepted: 17-MAY-2020 Published Online: 10-JUN-2020
DOI: http://dx.doi.org/10.17659/01.2020.0031
Abstract
Background: Disseminated fungemia due to non-candida yeast is emerging as an opportunistic infection in hematological malignancies with prolonged neutropenia. Invasive infections by Geotrichum spp. are extremely rare and constitute only about 1% of all non-candida yeasts. The mortality in such patients is high and is seldom reported in the literature. Case Report: Here we describe a middle-aged man with treatment-resistant Hodgkin's lymphoma who developed invasive Geotrichum capitatus infection during his neutropenic phase, with poor response to combination therapy with voriconazole and amphotericin B. Conclusion: Geotrichum capitatus is responsible for fatal fungemia in patients with prolonged neutropenia complicating hematological malignancies. Geotrichum species are considered intrinsically resistant to echinocandins. Fluconazole minimum inhibitory concentration (MIC) for this species remains high. A high index of suspicion is required in this patient-group to identify disseminated geotrichosis as delay in treatment worsens mortality. We recommend the use of voriconazole with amphotericin B in immunocompromised patients with a high risk of disseminated fungemia.
Keywords : Amphotericin B, Candida, Fungemia, Geotrichosis, Neutropenia, Voriconazole.
Article Options
FULL TEXT
ABSTRACT
PDF
PRINTER FRIENDLY VERSION
Search PubMed for
Search Google Scholar for
Article Statistics
Bookmark and Share

Androxal Medication Case Reports Journal

Expanding our scope, the Journal now encompasses an intriguing subset of articles specifically targeting treatments and patient outcomes related to the medication Androxal. This medication, primarily used in the treatment of male infertility, has shown unique potentials in diverse patient scenarios. Our studies with Androxal have given us an abundance of case reports, which demonstrate the multifaceted impact of this medication across therapeutic areas. This nuanced pharmaceutical perspective adds a fresh dimension to our regular case reports. Articles will reveal effective management processes, pinpointing how Androxal has proven beneficial where other treatments may have failed. In addition, the focus on Androxal will highlight instances of challenging or unexpected outcomes, where the medication may have interacted uniquely with the patient's unique biological system or interplayed with other treatments. As we forge ahead with this significant addition, we anticipate that our detailed case reports on Androxal will provide invaluable insights to both practitioners and patients navigating their medical journey with this medication.

© 2011 Journal of Case Reports

abortion pill online

Secure abortion pill tablets. There he could simply order pill for abortion online generic.There we could simply order generic site.
Last updated on Apr 05, 2024